Nature of Business and Significant Accounting Policies - Additional Information (Details) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||
---|---|---|---|---|---|---|---|
Jun. 30, 2025
USD ($)
Candidate
Platform
|
Mar. 31, 2025
USD ($)
|
Jun. 30, 2024
USD ($)
|
Mar. 31, 2024
USD ($)
|
Jun. 30, 2025
USD ($)
Candidate
Platform
|
Jun. 30, 2024
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
Nature Of Business [Line Items] | |||||||
Number of technology platforms | Platform | 2 | 2 | |||||
Number of clinical candidates in development | Candidate | 2 | 2 | |||||
Number of preclinical candidates in development | Candidate | 3 | 3 | |||||
Net loss | $ (6,204) | $ (6,408) | $ (5,883) | $ (6,834) | $ (12,612) | $ (12,717) | |
Accumulated deficit | (260,189) | (260,189) | $ (247,577) | ||||
Net cash used in operating activities | (13,668) | $ (12,804) | |||||
Nasdaq Capital Market | |||||||
Nature Of Business [Line Items] | |||||||
Net loss | (12,600) | ||||||
Accumulated deficit | $ 260,200 | 260,200 | |||||
Net cash used in operating activities | $ 13,700 |
X | ||||||||||
- Definition Nature Of Business [Line Items] No definition available.
|
X | ||||||||||
- Definition Number of clinical candidates in development. No definition available.
|
X | ||||||||||
- Definition Number of preclinical candidates in development. No definition available.
|
X | ||||||||||
- Definition Number of technology platforms. No definition available.
|
X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|